GSK3B and myeloid sarcoma: MS induced the marked enhancement and prolonged expression of p-GSK-3β and p-AKT, and PI3K inhibition attenuated the activation of GSK-3β and reduced IL-10 production, indicating the involvement of the PI3K-AKT-GSK-3β pathway in MS-induced IL-10 production.